Morey Blinder.jpg

Morey A. Blinder, MD

Professor
Department of Medicine
Hematology Division
Department of Pathology & Immunology

Clinical Interests

  • Disorders of iron metabolism
  • Sickle cell disease
  • Immune-mediated hematologic disease
  • Bleeding and thromboembolic disorders

Research Interests

  • Treatment of iron overload disorders and iron deficiency
  • Management of sickle cell disease
  • Treatment of ITP and TTP

Contact

  • 314-362-8814 (tel)
  • 314-362-8813 (fax)
  • Room 8814 Clinical Sciences Research Building (office)
  • Hematology Division
    Campus Box 8125
    Washington University School of Medicine
    660 South Euclid Avenue
    St. Louis, MO 63110

Biosketch

Education
1973-1977 BS, University of Notre Dame, Notre Dame, IN
1977-1981 MD, St. Louis University School of Medicine, St. Louis, MO
Post-graduate Training
1981-1984 Resident in Internal Medicine, Department of Medicine, University of Illinois School of Medicine, Chicago, IL
1984-1986 Fellow in Hematology, Department of Internal Medicine, University of Washington School of Medicine, Seattle, WA
1986-1990 Post-doctoral Research Fellow, Division of Hematology-Oncology, Washington University School of Medicine, St. Louis, MO
Academic Positions
1990-1998 Assistant Professor, Division of Laboratory Medicine, Washington University School of Medicine, St. Louis, MO
1994-present Medical Director, Wohl Hematology Laboratory
1996-present Associate Member, Alvin J. Siteman Cancer Center
1998-2013 Associate Professor of Medicine and Pathology & Immunology, Washington University School of Medicine, St. Louis, MO
2013-present Professor of Medicine and Pathology & Immunology, Washington University School of Medicine, St. Louis, MO
Appointments & Committees
1990-present Barnes-Jewish Hospital Medical Staff
2000-present Medical Staff Association, Barnes-Jewish Hospital
2005-2007 Vice Chair of the Executive Committee of the Faculty Council, Washington University School of Medicine
2007-present Transfusion Committee, Barnes-Jewish Hospital
2010-present Associate Director, Hematology-Oncology Fellowship Program
Board Certification
1984 Diplomate of the American Board of Internal Medicine
1987 Diplomate of the American Board in Medical Oncology
1988 Diplomate of the American Board in Hematology
Honors & Awards
1987-1989 Fellow of the American Heart Association, Missouri Affiliate
1990 European Patent Number 90870188.1 "Modified Heparin Cofactor II"; Inventors: DM Tollefsen, VM Derechin, MA Blinder
1992 U.S. Patent Number 5,102,995 "DNA Encoding Modified Heparin Cofactor II"; Inventors: DM Tollefsen, VM Derechin, MA Blinder
1992 U.S. Patent Number 5,118,793 "Modified Heparin Cofactor II "; Inventors: DM Tollefsen, VM Derechin, and MA Blinder
1995 Outstanding Teacher for the 1994-95 Academic Year, Department of Internal Medicine, Washington University School of Medicine
1999 Dr. Neville Grant Award for Clinical Excellence
2001-2012 Listed in Best Doctors in America
2001-2012 Listed in Castle Connolly America's Top Doctors
2004-present Missouri Genetic Disease Advisory Committee, Appointed by Governor Bob Holden; Reappointed by Governor Matt Blunt 2006; Reappointed by Governor Jay Nixon 2010
2008-present Chairman, Sickle Cell Anemia Standing Committee, State of Missouri, Department of Health and Senior Services
Professional Societies
1992 American Society of Hematology
1993 American College of Physicians, Member
1995 Academy of Clinical Laboratory Physicians and Scientists
Consulting Relationships & Board Memberships
2008-2011 Data and Safety Monitoring Board, National Institute of Neurologic Disorders and Stroke Desferoxamine in Intracranial Hemorrhage Trial
2011-present Chairman, Safety Monitoring Committee, National Heart, Lung and Blood Institute (NHLBI), Safety to Reduce Iron Deficiency (STRIDE) Study
2011-present Panel Member, NCCN Guidelines - Cancer and Chemotherapy-Induced Anemia